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Objective: To evaluate the different etiologies and clinical subtypes of bilateral vestibular 
hypofunction (BVH) and the value of diagnostic tools in the diagnostic process of BVH.
Materials and methods: A retrospective case review was performed on 154 patients 
diagnosed with BVH in a tertiary referral center, between 2013 and 2015. Inclusion 
criteria comprised (1) imbalance and/or oscillopsia during locomotion and (2) summated 
slow phase velocity of nystagmus of less than 20°/s during bithermal caloric tests.
results: The definite etiology of BVH was determined in 47% of the cases and the 
probable etiology in 22%. In 31%, the etiology of BVH remained idiopathic. BVH 
resulted from more than 20 different etiologies. In the idiopathic group, the percentage of 
migraine was significantly higher compared to the non-idiopathic group (50 versus 11%, 
p < 0.001). Among all patients, 23.4% were known with autoimmune disorders in their 
medical history. All four clinical subtypes (recurrent vertigo with BVH, rapidly progressive 
BVH, slowly progressive BVH, and slowly progressive BVH with ataxia) were found in 
this population. Slowly progressive BVH with ataxia comprised only 4.5% of the cases. 
The head impulse test was abnormal in 94% of the cases. The torsion swing test was 
abnormal in 66%. Bilateral normal hearing to moderate hearing loss was found in 49%. 
Blood tests did not often contribute to the determination of the etiology of the disease. 
Abnormal cerebral imaging was found in 21 patients.
conclusion: BVH is a heterogeneous condition with various etiologies and clinical charac-
teristics. Migraine seems to play a significant role in idiopathic BVH and autoimmunity could 
be a modulating factor in the development of BVH. The distribution of etiologies of BVH 
probably depends on the clinical setting. In the diagnostic process of BVH, the routine use of 
some blood tests can be reconsidered and a low-threshold use of audiometry and cerebral 
imaging is advised. The torsion swing test is not the “gold standard” for diagnosing BVH 
due to its lack of sensitivity. Future diagnostic criteria of BVH should consist of standardized 
vestibular tests combined with a history that is congruent with the vestibular findings.
Keywords: bilateral vestibulopathy, bilateral vestibular hypofunction, bilateral vestibular areflexia, bilateral 
vestibular loss, etiology, caloric tests, head impulse test, vestibular migraine
TaBle 1 | etiologies of BVh (3, 31–33).
idiopathic (51%)
Toxic/metabolic 
(13–21%)
Antibiotics, furosemide, cisplatin, aspirin, alcohol, 
vitamine-B12 deficiency, folate deficiency, hypothyroidism, 
styrene poisoning, combination non-steroidal anti 
inflammatory drug + penicillin
Infectious 
(3.8–12%)
Meningitis/encephalitis/cerebellitis, Lues, Behçet, Borrelia, 
Herpes Simplex Virus, bilateral neuritis
Autoimmune 
(10%)
Cogan, Susac, Sarcoïdosis, Wegener’s, Sjögren, colitis, 
celiac disease, polyarteritis nodosa, antiphospholipid 
syndrome, other systemic diseases
Neurodegenerative CANVAS, superficial siderosis, episodic ataxia, multiple 
system atrophy, polyneuropathy, SCA3, SCA6, hereditary 
sensoric and autonomic neuropathy type IV, other ataxias
Genetic DFNA9, DFNA11, DFNA15, DFNB4, mutation 
chromosome 5q, 6q, 11q, 22q Muckle Wells (NLPR3)
Vascular Supra- or infratentorial lesions, vertebrobasilar 
dolichoectasia
Neoplastic Bilateral vestibular schwannoma, Neurofibromatosis type 
2, metastasis lymphoma, malignant tumor
Trauma Head trauma, iatrogenic (e.g., bilateral CI-implantation)
Other ear 
pathology
Bilateral Ménière’s disease, otosclerosis, bilateral 
labyrinthitis, cholesteatoma
Congenital/
syndromal
e.g., CHARGE, Usher, Turner, enlarged vestibular 
aqueduct syndrome, Alport syndrome
Other presbyvertigo, vestibular atelectasis, auditory neuropathy 
spectrum disorders, etc.
March 2016 | Volume 7 | Article 262
Lucieer et al. BVH: Etiologies, Clinical Subtypes, Diagnostics
Frontiers in Neurology | www.frontiersin.org
inTrODUcTiOn
Bilateral vestibular hypofunction (BVH) is a heterogeneous 
chronic condition characterized by a bilateral reduced or absent 
function of the vestibular organs, the vestibular nerves or a 
combination of both (1–3). Patients can report a variety of symp-
toms, such as oscillopsia, imbalance, visual vertigo, cognitive 
deficits, autonomic symptoms, and impaired spatial orientation. 
Depending on the etiology, neurological symptoms can also be 
present (e.g., ataxia), as well as auditory symptoms, such as hear-
ing loss or tinnitus (4–7). BVH is an uncommon disorder and 
the estimated prevalence in 2008 was 28 per 100,000 US adults 
(8). The impact is still controversial and not always recognized. 
However, increasing evidence shows that BVH causes a high 
decrease in quality of life and imposes a high socio-economic 
burden due to work-related disabilities (9, 10).
Diagnosing BVH can be difficult and, therefore, BVH is 
often under- or misdiagnosed. Many challenges are met when 
establishing the diagnosis of BVH. Currently, many different 
diagnostic tests are used for vestibular evaluation, such as the 
caloric test, rotatory chair tests, (video) head impulse test (HIT), 
vestibular-evoked myogenic potentials (VEMP), dynamic visual 
acuity test (DVA), etc. (1, 4, 7). However, at this moment, no diag-
nostic standards regarding interpretation and implementation of 
vestibular test are available (7).
When the diagnosis of BVH is established in a patient, iden-
tifying the etiology still remains challenging. Previous studies 
showed that in 49–80% a definite or probable etiology could 
be defined, indicating that in 20–51% the etiology remained 
idiopathic (5, 11). The already identified etiologies of BVH vary 
tremendously (Table  1) (3, 12–27). The possible underlying 
causes of idiopathic BVH are still controversial. Studies suggest 
that migraine might play an important role and the prevalence of 
migraine has been shown to be higher in unclassified or idiopathic 
vertigo (28, 29). Furthermore, vestibular migraine is increasingly 
recognized as a cause of episodic vertigo (30). However, the rela-
tion between migraine and vertigo is not always recognized in 
clinical settings, since vertigo can precede headache, but may also 
begin with headache or appear later in the headache phase (28).
The variety in etiology of BVH is also reflected by different 
clinical manifestations of the disease. Currently, four different 
clinical subtypes have been described as follows: (1) recurrent 
vertigo and BVH: this clinical subtype is characterized by episodes 
of vertigo, followed by the development of symptoms of bilateral 
vestibular function loss. (2) Rapidly progressive BVH: patients 
experience a sudden onset or rapid progression in the course 
of BVH. (3) Slowly progressive BVH: the clinical symptoms of 
BVH develop gradually, mostly without episodes of vertigo. (4) 
BVH with neurological deficits: the clinical symptoms of BVH 
are combined with neurological deficits, such as peripheral poly-
neuropathy and/or cerebellar ataxia (4, 31).
Next to vestibular tests, many other tests, such as cerebral 
imaging, audiometry, and blood tests, can be used (on indication) 
in the diagnostic process. These tests do not evaluate the vestibular 
function and are mainly used to determine the etiology of BVH 
or coexisting problems (31). It is not yet established which tests 
should be part of the routine diagnostic work-up of BVH.
Overall, additional research is necessary to determine other 
possible etiologies of BVH and to fully understand the develop-
ment and clinical course of BVH. The objective of this retrospec-
tive study was to further investigate the different etiologies of 
BVH, the different clinical courses of the disease, and the value 
of some diagnostic tests currently used in the diagnostic process of 
BVH. This information could be valuable in the establishment 
of diagnostic criteria for BVH.
MaTerials anD MeThODs
ethical consideration
This study was performed in accordance with the guidelines 
outlined by Dutch legislation. According to the Medical Research 
Involving Human Subjects Act (WMO) ethical approval was not 
required due to the retrospective nature and anonymization of 
these data.
Patients
A retrospective case review was performed on all patients diag-
nosed with BVH by, or under the supervision of, the senior author 
at the vestibular department of Maastricht University Medical 
Center between 2013 and 2015. It was confirmed that the patients 
met the following diagnostic inclusion criteria: (1) imbalance 
and/or oscillopsia during locomotion and (2) reduced responses 
(summated slow phase mean peak velocity of the nystagmus 
of less than 20°/s) during bithermal caloric tests. If a patient 
chart did not comprise all the essential information necessary 
FigUre 1 | Distribution of certainty of etiology. A definite etiology was 
found in 47% of the BVH patients, a probable etiology in 22% of the BVH 
patients and in 31% the etiology of BVH remained idiopathic.
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to determine the etiology (including idiopathic  etiology), the 
patient was excluded. Time of diagnosis was based on the date on 
which the vestibular tests were performed.
Data collection
Clinical records were reviewed as well as all qualitative and 
quantitative data concerning medical history taking, familial 
history taking (e.g., vestibular disorders, genetic disorders, etc.), 
vestibular tests (oculomotor tests, caloric tests, torsion swing 
tests, HITs), neurological examinations, and other diagnostic 
tests. Other diagnostic tests comprised pure tone and speech 
audiometry, laboratory tests (vitamin B12, folic acid, HbA1c, 
TSH, fT4, Borrelial serology, treponemal serology, and genetic 
tests), cerebral computed tomography, and magnetic resonance 
imaging. These data were collected in IBM SPSS Statistics 21. 
The non-vestibular diagnostic tests had only been performed 
on indication. Indications comprised an idiopathic etiology or 
an etiology requiring further diagnostic tests (e.g., an MRI of 
the cerebellopontine angle in Ménière’s disease to rule out other 
possible causes). The etiologies of BVH were classified into three 
groups: definite, probable, or idiopathic etiology (5).
The caloric tests were performed in all patients with water at 
30 and 44°C. In 151 cases, the volume was 300  ml in 30  s. In 
three cases, the volume was uncertain, because the caloric test 
was performed elsewhere. Torsion swing tests were performed 
using sinusoidal rotation (0.11 Hz) with a peak velocity of 100°/s. 
An abnormal response was defined by a gain of <30%, based on 
the 95% confidence interval of the normative data obtained in the 
vestibular department of Maastricht University Medical Center. 
The horizontal manual HIT was considered abnormal when 
overt saccades were observed. The horizontal video head impulse 
was performed using the Eyeseecam system (EyeSeeCam VOG; 
EyeSeeCam, Munich, Germany). A video HIT was considered 
to be abnormal when pathological overt- and/or covert saccades 
were present in the raw eye traces and/or when patients showed 
a gain less than 0.6. Missing values from all diagnostic tests were 
reported as missing data and were not included in the analysis 
performed. Patients were diagnosed with Ménière’s disease using 
the diagnostic criteria for Ménière’s disease (34). The International 
Headache Society criteria for migraine were used to establish the 
diagnosis of migraine with or without aura (35).
statistical analysis
Modules from IBM SPSS Statistics 21 were used for statistical 
analysis. The chi-squared test was applied to test for differences 
and correlations in nominal values. A significance level of 
p < 0.05 was chosen to determine significant differences within 
and across groups.
resUlTs
In this study, 154 BVH patients were selected. The mean age of the 
patients was 60 ± 12.5 years (range 19–85) at the time of diagnosis. 
In one patient, no exact date of assessment could be determined. 
Of the study population, 52.6% was male and 47.4% female. 
Imbalance was experienced by 98.1% of the patients and 68.5% 
complained of oscillopsia.
etiology
Overall, the definite etiology of BVH was determined in 47% of the 
cases (N = 72) and the probable etiology in 22% (N = 34). In 31% 
(N = 48), the etiology of BVH remained idiopathic (Figure 1). In 
this study, BVH resulted from more than 20 different etiologies. 
The most frequent non-idiopathic etiologies were classified into 
genetic disorders (17%), Ménière’s disease (16%), ototoxicity 
(12%), infectious diseases (6%), and neurodegenerative diseases 
(4%) (Figure  2). The main groups and main observations will 
now be discussed.
Regarding genetic disorders, a definite diagnosis with a geneti-
cally confirmed mutation in the COCH gene was most prevalent 
(N = 15). In 11 patients, clinical presentation and family history 
were highly suggestive for genetic predisposition, but no genetic 
investigations were performed or no genetic mutation was found. 
In these patients, a genetic origin was, therefore, classified as the 
probable etiology.
Thirteen patients were diagnosed with bilateral Ménière’s 
disease and 12 patients with unilateral Ménière’s disease. In all 
12 patients diagnosed with unilateral Ménière’s disease, a bilateral 
vestibular function loss was found. One patient experienced only 
one vertigo attack and one patient did not have objective hear-
ing loss according to the diagnostic criteria of Ménière’s disease. 
Therefore, two patients were diagnosed as probable Ménière’s 
disease.
In the group of ototoxicity, BVH was related to treatment with 
Gentamycin in 14 patients. Two other cases resulted from treat-
ment with Tobramycin and Neomycin and in two patients BVH 
developed after chemotherapy. In one patient, a probable ototoxic 
cause was found due to treatment with Quinine.
In the group of infectious diseases, BVH was definitely related 
to meningitis in childhood in six patients. Three other cases most 
likely resulted from Rubella, Epstein–Barr Virus, and Lyme’s 
disease. The group of neurodegenerative diseases consisted solely 
of six patients with the suspected diagnosis of cerebellar ataxia 
with neuropathy and bilateral vestibular areflexia syndrome 
(CANVAS). Strikingly, 23.4% of all patients (N =  36) reported 
an autoimmune disease in their medical history. Among them, 
three patients were identified with Cogan’s syndrome and only 
FigUre 2 | Distribution of etiologies in the BVh group, divided into main groups of etiology and certainty of the etiology.
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seven patients suffered from Ménière’s disease. In 3% (N = 5), a 
neoplastic abnormality was found. Four patients suffered from 
a unilateral vestibular schwannoma and one patient had a skull 
base meningioma. Head trauma caused BVH in two patients 
(bilateral skull base fracture and labyrinth contusion) and two 
patients were known with congenital abnormalities. In two 
patients, vascular abnormalities (cerebrovascular accident and 
after carotid endarterectomy) were found. In one patient, BVH 
developed after organ transplantation and in two patients after 
bilateral cochlear implantation. In one patient, renal failure was 
the probable cause of BVH. In three patients, a combination of 
two different causes resulted in BVH.
In 31% (N = 48), the etiology of BVH remained idiopathic. 
The gender was equally distributed. Notably, the percentage of 
migraine among idiopathic patients was significantly higher 
compared to the group of patients with a definite or probable 
etiology of BVH (p < 0.001): 50% of the idiopathic BVH patients 
met the International Headache Society criteria (35) for migraine, 
in contrast to 11% in the non-idiopathic BVH group (Figure 3).
clinical subtypes of BVh
All four previously described clinical subtypes were found in this 
population (Figure  4). Recurrent episodes of vertigo, followed 
by the development of BVH were found in 36.4% (N = 56) of all 
patients. Ménière’s disease (N = 23), genetic disorders (N = 7) and 
idiopathic BVH (N = 21) were most accounted for this clinical 
subtype. In 36.4% of the cases (N =  56), a rapidly progressive 
BVH was found. The main cause of this acute impairment was 
ototoxicity due to the adverse effect of medication, in particular 
aminoglycoside antibiotics (N = 14).
Thirteen patients with this clinical subtype belonged to the 
idiopathic group. BVH developed slowly progressively in 20.8% 
(N = 32) of the patients. In most cases, it comprised patients with 
a genetic disorder or patients from the idiopathic group. Slowly 
progressive BVH combined with neurological deficits was found 
in 4.5% (N = 7) of the cases. Six of these patients were suspected 
of CANVAS. Missing data arose in 1.9% of all cases.
Diagnostic Tests
According to the inclusion criteria, bithermal caloric tests showed 
reduced responses with a summated slow phase velocity (SPV) of 
the nystagmus of less than 20°/s in all 154 patients. A mean of 
6.3 ± 6.3°/s (range 0–19) was found. The HIT was abnormal in 
109 out of 116 tested patients (94%). The seven head impulses 
that were considered to be normal, all involved manual HITs. In 
38 patients, no data were found concerning the HIT. Data about 
the torsion swing test were present in 143 patients, of which 94 
showed reduced responses (66%) (Table 2).
Pure tone and speech audiometry was performed in 143 
patients. In 49% of these patients, there was normal hearing or 
only moderate hearing loss in both ears (modified Fletcher Index: 
0–49 decibel). No hearing loss was found in 22 patients. In 36% of 
the patients, an asymmetric hearing loss was found. The results of 
the pure tone audiometry are presented in Table 3.
When indicated, patients were screened for abnormal levels of 
vitamin B12, folic acid, HbA1c, TSH, and fT4. Most strikingly, a 
vitamin B12 deficiency was found in 26 patients and a high folic 
acid was present in 27 patients. In eight patients, a combination 
of both findings was seen. Most cases involved a mild vitamin 
B12 deficiency, probably not related to the development of BVH. 
High levels of HbA1c were only found in patients already known 
with diabetes mellitus. In seven patients, abnormal thyroid func-
tion was found, of which three patients were known with thyroid 
dysfunction. In not one of these patients, a relation with regard 
to the development of BVH was suspected. An overview of blood 
test results is presented in Table 4. Approximately, one-third of 
all patients were tested for antinuclear antibodies (ANA) and 
anti-neutrophil cytoplasmic antibodies (ANCA). In six patients, a 
positive ANA, without a positive ANCA, was found. One of them 
was known with autoimmune disorders (rheumatoid arthritis, and 
diabetes mellitus type I) and one of them with Ménière’s disease. In 
the remaining four patients, the positive ANA was a new finding 
and they were referred to an immunologist. In only one of them, 
an underlying autoimmune disorder was suspected and the patient 
was treated with corticosteroids. In one patient, an atypical pattern 
TaBle 2 | results of torsion swing test and head impulse test.
Torsion  
swing (n)
normal abnormal not tested Total
(V)hiT
Normal 4 2 1 7
Abnormal 36 66 7 109
Missing data 9 26 3 38
Total 49 94 11 154
FigUre 4 | clinical subtypes of BVh with respect to the etiologies in the BVh group.
FigUre 3 | Presence of migraine in the idiopathic BVh group versus the non-idiopathic BVh group. In the idiopathic BVH group, migraine was significantly 
more present than that in the non-Idiopathic BVH group (50% versus 11%, p < 0.001).
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of ANCA was found, without a positive ANA. This patient was 
already known with an autoimmune disorder (rheumatoid arthri-
tis) (Table  5). Seventy-three patients were tested for antibodies 
against the Borrelia bacteria, of which five showed results of a 
previous Borrelial infection, without any signs of a recent infection 
or a history of typical complaints of neuroborreliosis. If necessary, 
a virologist was consulted. In two cases (3%), it was decided to still 
treat the patients against the Borrelial infection. Forty-one patients 
were screened for antibodies against the Treponema  pallidum 
bacteria and no abnormalities were found (Table 5).
Cerebral imaging studies were performed in 127 patients 
(N = 119 MRI; N = 8 CT) (Table 6). The following abnormalities 
were found: cerebellar atrophy (N = 4), cerebellar lesions (N = 3), 
unilateral vestibular schwannoma (N = 4, of which two patients 
did not have asymmetric hearing loss), supra- or infratentorial 
vascular lesions (N = 5), a skull base meningioma (N = 1), and 
abnormalities of the semicircular canals (e.g., fibrosis, calcifica-
tion, inflammation, N =  4). No new abnormalities were found 
with computerized tomography. In three patients, abnormalities 
found with cerebral imaging were already expected due to previ-
ous findings on MRI or medical history. In 18 patients (14%), 
cranial imaging studies revealed new findings.
DiscUssiOn
In this study, 154 patients were evaluated with regard to the differ-
ent etiologies of BVH, clinical subtypes of BVH, and diagnostic 
TaBle 5 | results auto-antibodies and bacteria in BVh patients.
results ana anca Treponema pallidum (igM) Borrelia bacteria (igM) Borrelia bacteria (igg)
Negative 50 51 41 71 66
Positive 6 0 0 2 7
Atypical 0 1 – – –
Total 56 53 41 73 73
Clinical implication 1 0 0 0 2
Not tested 98 102 113 81 81
TaBle 4 | Blood test results in BVh patients.
results Vitamin B12 Folic acid hba1c Tsh fT4
Low 26a 1 – 2 –
Normal 39 32 44 60 56
High – 27 4 3 2
Total 65 60 48 65 58
Not tested 89 94 106 89 96
aThree patients were known with anemia in medical history due to Vitamin B12 deficiency.
TaBle 3 | results of pure tone audiometry.
impairment hearing loss Fi-high (dB) asymmetric hearing symmetric hearing
Best ear Worst ear Best ear Worst ear
No impairment 0–19 17 0 28 21
Slight impairment 20–34 10 6 19 21
Moderate impairment 35–49 10 8 11 14
Significant impairment 50–64 10 3 9 3
Severe impairment 65–79 3 8 7 11
Profound impairment: including deafness >80 5 30 14 18
Not tested 11
Total patients 154 55 55 88 88
TaBle 6 | Mri and cT in BVh patients.
Type N (%)
MRI Normal 98 (63.6)
N = 119 Abnormal Cerebellar atrophy 4 (2.6)
Cerebellar lesions 3 (1.9)
Unilateral VS 4 (2.6)
Supra- or infratentorial vascular lesions 5 (3.2)
Other 5 (3.2)
CT Normal 8 (5.2)
N = 8 Abnormal 0 (0)
Not tested 27 (17.5)
Total 154 (100)
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tests to establish the diagnosis of BVH. Although the etiology of 
BVH could often be defined, 31% of the cases remained idiopathic. 
Remarkably, the prevalence of migraine in this idiopathic group 
was significantly higher compared to the non-idiopathic group. 
The different etiologies of BVH were partly reflected by the four 
clinical subtypes, as previously described (4, 31). Not all patients 
showed a pathological HIT or reduced responses with the torsion 
swing tests. Audiometry often contributed to the determination 
of the etiology (e.g., Ménière’s disease) and in this population, 
blood tests did not often contribute to the determination of 
the cause of BVH. Abnormal cerebral imaging was found in 21 
patients.
etiologies
Patients were classified as having a definite, probable, or idiopathic 
etiology of BVH. Once etiology was not entirely certain or could 
not be confirmed with genetic research (e.g., CANVAS patients), 
etiology was described as a probable cause of BVH. Therefore, 
the amount of definite causes of BVH is probably a conservative 
estimation.
Genetic disorders and Ménière’s disease were the most frequent 
non-idiopathic causes of BVH in this population. Regarding 
genetic disorders, most patients presented with a mutation in 
their COCH gene. This mutation has been identified to cause 
autosomal dominant non-syndromic hearing loss accompanied 
by vestibular disorders (DNFA9) (13). Due to the high prevalence 
of DNFA9 in the Netherlands and Flanders (36), it is possible that 
the presence of DFNA9 was higher in this population of BVH 
patients. Although a strong underlying familial character seems 
to be present in multiple vestibular disorders, genome-wide asso-
ciation studies remain very difficult to perform, partly due to the 
clinical heterogeneity of vestibular disorders (12, 37). Therefore, 
BVH patients suspected of a genetic disorder (based on clinical 
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manifestation and family history) other than a confirmed COCH 
gene mutation, were classified as having a genetic disorder as the 
probable cause of BVH.
Regarding Ménière’s disease, a unilateral Ménière’s disease was 
found in 12 cases, in which no definite etiology could be deter-
mined to explain the vestibular hypofunction of the “unaffected” 
side. In some cases, bilateral Ménière’s disease was suspected on 
history, but no objective hearing loss could be defined with pure 
tone audiometry. However, other cases did not report any coch-
lear symptoms on the “unaffected” side. It probably shows that 
the vestibular system can (already) be affected bilaterally, while 
cochlear symptoms are present on only one side. This is in line 
with a previous study that showed that abnormal VEMP’s were 
present in 27% of the “unaffected” ears in unilateral Ménière’s 
disease (38). This bilateral vestibular involvement in a clinically 
unilateral Ménière’s disease has also important clinical implica-
tions: it shows that the use of diagnostic parameters, such as the 
interaural asymmetry in calorics and VEMP’s is not sufficient for 
diagnostic purposes in Ménière’s disease (3, 31, 38, 39).
Furthermore, when intratympanic gentamicin treatment is 
considered for intractable unilateral Ménière’s disease (40), an 
ENG should always be performed to determine the vestibular 
function of the “unaffected” side. If not performed, this could 
imply a risk of inducing an even more severe BVH.
Neurodegenerative diseases and ataxia were found in only 
seven patients, which varies tremendously compared to earlier 
studies (5, 11). This finding could imply that the distribution of 
the etiologies of BVH depends on the clinical setting in which 
patients are seen. In this study, patients were selected at the ves-
tibular department of the Department of Otorhinolaryngology 
and Head and Neck Surgery in Maastricht University Medical 
Centre, whereas in previous studies patients were selected in 
neurological departments (5, 11). This could explain the low 
percentage of BVH with neurological deficits and might also be 
the reason why fewer patients showed a slow progression of BVH, 
which is usually seen in patients with neurological disorders (20). 
Overall, the “real” BVH population is probably a reflection of 
both study populations.
A unilateral vestibular schwannoma with bilateral vestibular 
loss was found in four patients. This is an atypical finding, since 
BVH is mainly found when schwannomas appear bilaterally 
as in neurofibromatosis type II (41), not unilaterally. To our 
knowledge, literature has not reported about this type of finding. 
However, most studies about schwannomas report on labyrin-
thine asymmetry in calorics, without incorporating the absolute 
values (42–46). This increases the chance of missing a symmetric 
low vestibular response (3). A possible explanation for the ves-
tibular loss on the contralateral side could be an endolymphatic 
hydrops on this side (47). Nevertheless, regarding the etiology 
of vestibular hypofunction on the side without a schwannoma, a 
definite cause could not be established, although in one out of the 
four cases, vestibular symptoms worsened after treatment with 
Gamma Knife.
Among all 154 BVH patients, 23.4% were known with auto-
immune disorders in their medical history. Only in the three 
patients with Cogan’s syndrome, a definite causal relationship 
could be identified between BVH and autoimmunity. Seven of 
the patients with a known autoimmune disorder suffered from 
Ménière’s disease, resulting in a possible link between BVH and 
autoimmunity (48, 49). However, the percentage of autoimmune 
disorders in western countries is only around 8% of the total 
population (50), in contrary to the 23.4% found in this popula-
tion. Therefore, autoimmune disorders might not always cause 
BVH directly, but could probably play a modulating role in the 
development of the disease.
In 31%, the etiology of BVH remained idiopathic. This differs 
from previous results in a large relatively recent study, in which in 
approximately 51% no definite or probable etiology of BVH could 
be defined (5). This difference could partially be explained by the 
increased knowledge regarding the underlying cause of BVH, the 
relatively high prevalence of genetic disorders in this population 
and the different clinical settings in which patients were seen. 
Notably, 50% of the idiopathic patients reported a history of 
migraine headaches according to the criteria of the International 
Headache Society. This was significantly higher than that in the 
non-idiopathic group and higher than would be expected in the 
normal population: migraine normally affects only 8% of males 
and 17% of females (51, 52). Next to the link between migraine 
and vertigo in vestibular migraine (30, 35), a suggestive linkage 
between migraine and BVH has been proposed before (4, 53). 
This study seems to confirm that migraine might play a significant 
role in the idiopathic variant of BVH and it shows the importance 
of screening for migraine features in the diagnostic process of 
BVH. In the future, additional studies could focus on the role of 
migraine in BVH and, in particular, the non-classical manifesta-
tions of this disease.
clinical subtypes
Most non-idiopathic BVH patients presented with a clinical sub-
type that would be expected with respect to their etiology (e.g., 
mainly rapidly progressive symptoms after ototoxic medication). 
Among the idiopathic BVH patients, all four different clinical 
subtypes were reported, showing an overlap between the clinical 
presentations of non-idiopathic and idiopathic BVH. This is one 
of the contributing factors of the challenging diagnostic process 
of BVH (3, 4, 31).
Vestibular Tests and inclusion criteria
Caloric Test
Inclusion criteria comprised reduced responses during bith-
ermal caloric irrigations. However, absent responses during 
bithermal caloric irrigations do not necessarily indicate a com-
plete loss of the vestibular function (7). Therefore, symptoms 
had to match caloric findings in order to get a more specific 
selection of patients. In addition to that, other vestibular tests 
were evaluated.
(Video) Head Impulse Test
In contrast to previously proposed criteria (7), a positive HIT was 
not included in the inclusion criteria due to the following reasons: 
(1) a bilateral pathological HIT was previously found in only 
73% of a BVH population, suggesting that a normal HIT does 
not necessarily rule out a vestibular deficiency (1). (2) A manual 
HIT observed with the naked eye of experts is false negative in 
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about 50% of the patients, when compared to the VHIT (31). 
In this study, all HITs performed with a VHIT-system showed 
pathological responses, in contrary to some manually performed 
HITs. Since a manual HIT can be false negative, it cannot be ruled 
out that (some of) the manual HITs in this study were actually 
false negative ones. Nevertheless, around 94% of all HITs cor-
responded with the findings during bithermal caloric irrigations. 
Taking these findings into account for the future diagnostic 
process of BVH, we would strongly suggest performing a VHIT 
instead of a manual HIT.
Torsion Swing Test
Although the torsion swing test is sometimes considered to be 
the “gold standard” for BVH (3), it was not included in the inclu-
sion criteria since it is very specific, but seems to have a lower 
sensitivity, leading to false negative results (7, 31). In this study, 
only 66% of the tested patients showed an abnormal response 
with the torsion swing test at 0.11 Hz, implying a possible lack of 
sensitivity. The preservation of vestibular responses in the torsion 
swing test can possibly be explained by two hypotheses. (1) The 
torsion swing test stimulates the vestibular system closer to the 
optimum frequency sensitivity of the semicircular canals than 
the caloric test and the HIT (54, 55). When vestibular function 
would decline evenly distributed between frequencies in BVH, 
the vestibular system is most likely to longer preserve its response 
around the frequencies with optimum sensitivity. (2) In contrast 
to the caloric test and HIT, torsion swing testing is most likely 
to have more input from the otolith system (7). Since VEMP’s 
and DVAs were performed in only the minority of patients, 
they were not used in the total analysis. Therefore, inputs from 
otoliths during the torsion swing test could not be ruled out in 
this BVH population. For the future diagnostic process of BVH, 
torsion swing testing can be used complementarily (e.g., measure 
severity of BVH when the caloric test and HIT show no responses 
anymore) but not as the only test to diagnose BVH (31, 56).
Limitations of This Study Regarding Vestibular Tests
Inclusion criteria comprised vestibular symptoms combined with 
reduced responses during bithermal caloric tests. The selected 
patient group does, therefore, probably not reflect the whole 
BVH population, since the caloric test can miss, e.g., selective 
mid- to high-frequency loss of canals or isolated dysfunction 
of the otoliths. Depending on the diagnostic criteria for BVH, 
this leads to a lower sensitivity (7, 57). Next to this, specificity 
could be compromised by the fact that reduced caloric responses 
not always indicate a true vestibular loss. Uncontrollable factors, 
such as anatomy of the temporal bone could lead to reduced tem-
perature conduction and as a consequence lead to false-positive 
results (58). However, since no diagnostic criteria for BVH are 
available yet and VEMP’s and DVAs were only performed in the 
minority of patients, it was decided to only use the caloric test as 
a parameter for the vestibular function. Nevertheless, VEMP’s, 
DVAs, and motion perception might play a more important role 
in the future diagnostic process of BVH (7, 31, 59–62) and our 
research group is, therefore, prospectively testing these param-
eters in BVH patients (not yet published).
Other Diagnostic Tests
Currently, many other diagnostic tests are used for determination 
of coexisting problems or the etiology of BVH (31). Some of them 
will be briefly discussed below.
Audiometry
Audiometry often contributed to the determination of the under-
lying etiology (e.g., Ménière’s disease) of BVH and seems to be a 
valuable diagnostic tool when indicated. Considering otoacoustic 
emissions were not performed in these BVH patients, auditory 
neuropathy could have been missed during the determination of 
the etiology. Nevertheless, speech audiometry was performed on 
these patients, and as poor speech recognition is also a criterion 
of auditory neuropathy disorder, this obstacle could partially be 
overcome by these tests (32, 63–65). Notably, in approximately 
half of the patients, no to moderate hearing loss was found by 
using pure tone and speech audiometry. It shows the importance 
of hearing preservation during vestibular implantation, in case a 
vestibular prosthesis would become a clinically useful therapeutic 
device in the future (66–71).
Blood Tests
In this study, blood tests results of vitamin B12, folic acid, HbA1c, 
TSH, and fT4 showed that in case of abnormal blood results, no 
strong clinical implications were found with regard to the diagnosis 
or treatment of BVH. Limitation of this retrospective study was the 
fact that patients were referred to their general practitioner or other 
specialists for further diagnostics and follow-up of their vitamin 
B12 deficiency and high levels of folic acid. Not all data could be 
obtained. Nevertheless, the use of some of the blood tests (HbA1c, 
TSH, fT4) could be reconsidered in the diagnostic trial of BVH.
Although autoimmunity might play a role in the pathogenesis 
of some BVH subpopulations (72), the use of routine ANA and 
ANCA antibodies yielded little in this population. Seven patients 
showed positive results for ANA or ANCA, but some of the ANA 
positive results might be attributed to the fact that ANA positivity 
is also found in a certain percentage of normal individuals (73). 
The positive ANA in the patient with Ménière’s disease could be 
explained by a relation between Ménière’s disease and autoim-
mune diseases, described in earlier studies (48, 49, 74). Eventually, 
only 1 out of 157 tests had a clinical consequence: the patient was 
treated for a suspected autoimmune disorder. Therefore, in the 
future diagnostic process of BVH, routine testing of ANA and 
ANCA could probably be redundant and might be reserved for 
more specific cases with a higher suspicion of an underlying auto-
immune disorder. However, the routine use of inner ear-specific 
auto-antibodies should still be investigated (72).
Two out of 73 patients tested for Borrelia were eventually 
treated for a Borrelial infection. The relation between BVH and 
Borrelia remained questionable in these cases due to the absence 
of typical complaints of neuroborreliosis and the fact that it can be 
a diagnostic challenge to prove that a neurological manifestation 
has been caused by Borrelia (75). This is due to the low positive 
predictive value of the test. Still, the negative predictive value is 
very high (76, 77). Although only a few cases were suspected of 
BVH due to a Borrelial infection, it should be noted that Borrelia 
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is a non-endemic infectious disease in the demographic area in 
which patients were selected for this study (78). Therefore, blood 
tests to identify infection with the Borrelia bacteria might still be 
important, especially in areas were the bacteria is active.
Neurosyphilis has also a low incidence in the Netherlands, par-
tially explaining the absence of antibodies against the Treponema 
pallidum bacteria in this BVH population. Nevertheless, screen-
ing for Treponema can still be considered in risk groups and in 
areas where treponemes are known to be endemic (79, 80).
Cerebral Imaging
Cerebral imaging studies revealed new findings in 18 patients, 
which is less compared to previous studies (5, 81), but this is again 
probably related to the study group. Cerebral imaging has shown 
to play an important role in the diagnosis of BVH, reflected by 
the new findings detected by MRI. In addition to that, cerebral 
imaging is also inherent to some diagnostic work-ups (e.g., an 
MRI in Ménière’s disease to rule out other possible causes) (34). 
Therefore, in the future diagnostic process of BVH, cerebral 
imaging should be performed in cases with a less clear etiology 
of BVH as well as within the framework of diagnostic work-ups. 
In most cases, MRI would be the preferred modality.
cOnclUsiOn
Bilateral vestibular hypofunction is a heterogeneous condition 
with various etiologies and clinical characteristics. Migraine 
seems to play a significant role in idiopathic BVH and autoim-
munity could be a modulating factor in the development of BVH. 
The distribution of etiologies of BVH probably depends on the 
clinical setting. In the diagnostic process of BVH, the routine use 
of some blood tests can be reconsidered and a low-threshold use 
of audiometry and cerebral imaging is advised. The torsion swing 
test is not the “gold standard” for diagnosing BVH due to its lack 
of sensitivity. Future diagnostic criteria of BVH should consist 
of standardized vestibular tests combined with a history that is 
congruent with the vestibular findings.
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